- Report
- May 2022
- 83 Pages
Global
From €1992EUR$2,000USD£1,651GBP
- Report
- May 2022
- 176 Pages
Global
From €1992EUR$2,000USD£1,651GBP
- Report
- May 2022
- 65 Pages
Global
From €1992EUR$2,000USD£1,651GBP
- Report
- August 2024
- 93 Pages
China
From €1793EUR$1,800USD£1,486GBP
- Report
- March 2024
- 132 Pages
Global
From €946EUR$950USD£784GBP
- Report
- December 2023
- 132 Pages
Global
From €946EUR$950USD£784GBP
- Report
- November 2021
- 620 Pages
Global
From €3984EUR$4,000USD£3,303GBP
- Report
- February 2023
- 385 Pages
Global
From €3556EUR$3,570USD£2,948GBP
- Report
- February 2023
- 349 Pages
Global
From €3556EUR$3,570USD£2,948GBP
- Report
- October 2022
- 290 Pages
Global
From €3556EUR$3,570USD£2,948GBP
- Report
- January 2022
- 205 Pages
Global
From €3697EUR$3,712USD£3,065GBP
- Report
- November 2021
- 220 Pages
Global
From €3697EUR$3,712USD£3,065GBP
- Book
- September 2023
- 288 Pages
The Antivirals market is a subset of the Infectious Diseases Drugs market, which includes drugs used to treat viral infections. Antivirals are used to treat a wide range of viral infections, including influenza, HIV, herpes, hepatitis, and other respiratory infections. Antivirals work by targeting the virus itself, preventing it from replicating and spreading throughout the body. They can also be used to reduce the severity of symptoms and shorten the duration of the illness.
Antivirals are typically administered orally or intravenously, depending on the type of virus and the severity of the infection. In some cases, antivirals may be used in combination with other drugs to increase their effectiveness.
Some of the major companies in the Antivirals market include Gilead Sciences, Merck & Co., Pfizer, GlaxoSmithKline, and Bristol-Myers Squibb. These companies produce a variety of antiviral drugs, including those used to treat influenza, HIV, herpes, and hepatitis. Show Less Read more